Revolution Medicines, Inc. (RVMD)

186.99 -0.70 (-0.37%) USD  |  NASDAQ  |  Oct 23, 16:00
184.37 -2.62 (-1.40%) After-Hours: 20:00
More

Revolution Medicines Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Moderna, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Twist Bioscience Corp. Upgrade